Please assess the completion status of the following clinical trial:

Trial Title: Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-64 years (both inclusive) at the time of signing informed consent~* Body mass index 18.5-28.0 kg/m\^2 (both inclusive)~* Subject who is considered to be healthy based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator~Exclusion Criteria:~* Known or suspected hypersensitivity to trial products or related products~* Previous participation in this trial. Participation is defined as informed consent~* Presence of clinically significant acute and chronic gastrointestinal symptoms (e.g. nausea, vomiting, heartburn or diarrhoea) within 2 weeks prior to first dosing, as judged by the investigator

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- Eating meal immediately after dosing (Type: EXPERIMENTAL): None
- Eating meal 30 min after dosing (Type: EXPERIMENTAL): None
- Eating meal 1 hour after dosing (Type: EXPERIMENTAL): None
- Eating meal 6 hour after dosing (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).